CTLA4 and parasitic infectious disease: While CTLA‐4 blockade improved control of acute parasitemia in mice, it was also found to worsen experimental cerebral malaria disease outcomes (Jacobs et al, 2002; Lepenies et al, 2007), suggesting a protective role for this receptor in the development of T cell‐mediated organ‐specific syndromes during acute infection.